Investing Profile

Ed Mathers

VCInvestor
Partner at New Enterprise Associates (NEA)
Photo of Ed Mathers, Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
New Enterprise Associates (NEA) Network
42 CONNECTIONS
New Enterprise Associates Network
16 CONNECTIONS
cb
$2.0M - $50.0M
$25.0M
50
$6.2B
CompanyStageDateRound SizeTotal Raised
Brenig Therapeutics
Series AJul 2024$65M
$65M
Cardurion Pharmaceuticals
Series BJul 2024$260M
$260M
Co-investors: Amy Schulman (Polaris Partners)
MBX Biosciences
Series BNov 2022$120M
Series AJul 2020$35M
$150M
Co-investors: Carl Gordon (OrbiMed), Patrick Heron (Frazier Healthcare Partners)
Inversago Pharma
Series COct 2022$69M
$110M
Co-investors: Elizabeth Douville (Amorchem), Marco Boorsma (Forbion), Nanna Luneborg (Forbion)
Code Biotherapeutics
Series AJun 2022$75M
SeedApr 2021$10M
$85M
Co-investors: Victor Stone (Takeda Ventures), Diana Bernstein (Northpond Ventures), Dima Kuzmin (4BIO Capital)
Sentry
Series EMay 2022$90M
Series DFeb 2021$60M
Series CSep 2019$40M
$220M
Co-investors: Daniel Levine (Accel), Chetan Puttagunta (Benchmark), Jay Simons (Bond), Ilya Sukhar (Matrix)
Trevi Therapeutics
Post Ipo EquityApr 2022$55M
Series CJan 2019$10M
Series CAug 2018$11M
Series CJul 2017$30M
$110M
Splice Bio
Series AFeb 2022$57M
$57M
Co-investors: Sylvain Sachot (Asabys Partners), Joël Jean-Mairet (Ysios Capital), Beat Steffen (Novartis Venture Fund)
Partner New Enterprise Associates (NEA)Present
Partner New Enterprise Associates2008 - Present
NC State University Bachelor of Science (BS)